Latest News and Press Releases
Want to stay updated on the latest news?
-
Boston, July 29, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Colonoscopes: Global Markets” is projected to reach $3.4 billion by the end of 2030, growing at a CAGR of...
-
Urteste S.A. Completes Development of Panuri Test – Company Plans to Launch Clinical Study in Q3 2025 Gdańsk, Poland - July 21, 2025 - Urteste S.A. (Warsaw Stock Exchange: URT), a company...
-
Boston, June 17, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Radiopharmaceuticals: Technologies and Global Markets” is expected to grow from $10.3 billion in 2024...
-
ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage
-
27 MARCH 2025 PRESS RELEASE Urteste plans to start clinical trials for its pancreatic cancer test in Europe in Q3 2025 Gdańsk, Poland – 27 March 2025 – Urteste S.A. (Warsaw Stock...
-
Rockville, MD, March 11, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global breast cancer diagnostics market is estimated to reach a...
-
Vara's PRAIM study shows AI boosts breast cancer detection by 17.6% in German screening of 500,000 participants; cutting radiologist workloads by 43%
-
Vara, the healthcare technology company revolutionizing breast cancer screening with AI, raises $8.9M in funding
-
Urteste Expands Development of Innovative Diagnostic Projects Gdańsk, Poland – 26 SEPTEMBER 2024, 16:00 CET - Urteste S.A. (Warsaw Stock Exchange: URT), a biotechnology company...
-
28 MAY 2024 PRESS RELEASE Urteste has successfully developed a prototype urine-based diagnostic test for detecting brain tumours Gdańsk, Poland – 28 MAY 2024, Urteste S.A. (Warsaw Stock...